{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:13:52Z","timestamp":1789370032143,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jns.2014.05.014","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T08:51:20Z","timestamp":1400143880000},"page":"180-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder"],"prefix":"10.1016","volume":"343","author":[{"given":"Eva","family":"Wuerfel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.05.014_bb0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.jns.2014.05.014_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/practneurol-2013-000511","article-title":"Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome","volume":"14","author":"Stern","year":"2014","journal-title":"Pract Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaneurol.2013.4442","article-title":"Childhood Onset of Stiff-Man Syndrome","volume":"70","author":"Clardy","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamaneurol.2013.1872","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies","volume":"70","author":"Damasio","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0030","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.05.014_bb0035","unstructured":"Carvajal-Gonzales A, Leite I, Waters P, Woodhall M, Coutinho E, Balint B, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain, [pending invited resubmission]."},{"key":"10.1016\/j.jns.2014.05.014_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1212\/WNL.0b013e318207b008","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy","volume":"76","author":"Clerinx","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.05.014_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbis encephalitits","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2014.05.014_bb0055","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jns.2014.05.014_bb0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/epi.12528","article-title":"Investigation of neuronal antibodies in two different focal epilepsy syndromes","volume":"55","author":"Ekizoglu","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2014.05.014_bb0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/epi.12405","article-title":"Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies","volume":"54","author":"Suleiman","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2014.05.014_bb0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/epi.12142","article-title":"Autoimmune epilepsy in children: case series and proposed guidelines for identification","volume":"54","author":"Suleiman","year":"2013","journal-title":"Epilepsia"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14003049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14003049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T13:36:29Z","timestamp":1565444189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14003049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":14,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0022510X14003049"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.05.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}